Interventional Cardiology News and Research

RSS

CRF to release new international journal focusing on diagnosis, treatment of structural heart disease

The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.

11 Nov 2016

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

A first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior in-stent late lumen loss at nine-months compared with historical zotarolimus-eluting stent (Resolute) data. In addition, there was no binary restenosis, and a high degree of early stent strut coverage with minimal malapposition.

2 Nov 2016

NOBLE study shows superiority of CABG over PCI for treatment of left main coronary artery disease

Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main coronary artery (LMCA) disease, but use of percutaneous coronary intervention (PCI) for this indication is increasing.

2 Nov 2016

PLATINUM DIVERSITY study evaluates clinical outcomes after stent implantation in women, minorities

A dedicated stent study conducted exclusively in women and minority patients evaluated clinical outcomes within the era of contemporary PCI, comparing these results to a parallel cohort of white male patients.

2 Nov 2016

RESPECT study: PFO closure more beneficial than medical management in reducing recurrent stroke

Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke.

2 Nov 2016

TCT 2016 features first report investigations on novel bioresorbable stents

The 28th annual Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation featured a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.

1 Nov 2016

Caisson announces successful human implants of Transcatheter Mitral Valve System

Caisson Interventional, LLC announces the first successful human implants of its fully percutaneous, transvascular mitral valve implant designed as a functional replacement in a diseased, damaged, or malfunctioning mitral valve.

21 Sep 2016

UCLA cardiology expert offers simple tips for heart healthy lifestyle

Living a heart healthy lifestyle is not about doing just one thing. Other steps are important too.

8 Sep 2016

MedStar Heart & Vascular Institute offers bioresorbable stent for patients with clogged arteries

A heart stent that slowly dissolves into the body is now available for patients with clogged arteries.

31 Aug 2016

Direct catheter-based thrombectomy equally effective to bridging thrombolysis in acute ischaemic stroke

Direct catheter-based thrombectomy is equally effective to bridging thrombolysis in the treatment of acute ischaemic stroke, according to results from the observational PRAGUE-16 registry study presented at ESC Congress 2016 today.

28 Aug 2016

Sutter Health among the first to offer Absorb dissolving stent for patients with coronary artery disease

Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new treatment option, the Abbott Absorb stent, which literally disappears in the body over time.

30 Jul 2016

MID's Permaseal transapical access and closure device receives FDA Market clearance

Micro Interventional Devices, Inc., the world leader in minimally invasive and catheter-based compliant fixation technologies addressing structural heart disease announced today that it received FDA Market clearance for the Company's first product: Permaseal transapical access and closure device.

30 Jul 2016

Essential Medical receives CE Mark approval for novel vascular closure device

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.

18 Jul 2016

Loyola among first health systems to offer absorbable stent to heart patients

Loyola Medicine will be among the first health systems in the country to offer heart patients a new stent that is absorbed by the body once it has served its purpose.

7 Jul 2016

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced that results from the Tryton Confirmatory Study of the company’s Side Branch Stent have been published in JACC Cardiovascular Interventions.

6 Jul 2016

Radial access gains ground over femoral route for PCI

A meta-analysis supports that radial access delivers better outcomes and improved safety than femoral access in patients undergoing percutaneous coronary intervention.

2 Jul 2016

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

A first-in-human trial of an everolimus-eluting bioresorbable vascular scaffold has shown that the device can achieve a high 2-year patency rate and low 2-year target lesion revascularisation rate in patients with peripheral artery disease involving the external iliac artery and superficial femoral artery.

23 Jun 2016

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Aortic stenosis means narrowing of the aortic valve, which is the out flow valve from the left ventricle, the pumping chamber of the heart. This is the valve which opens to allow blood to flood out of the heart and all-round the body.

22 Jun 2016

Persistent low flow warns of mortality risk after TAVR

Patients with persistent low flow at discharge after transcatheter aortic valve replacement have an increased risk of dying during the subsequent year, report researchers.

21 Jun 2016

Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Aortic stenosis (AS), the narrowing of the aortic valve in the heart which causes restricted blood flow, is one of the most common and serious valve disease problems. For patients with one type of AS - low flow - transcatheter aortic valve replacement (TAVR), a minimally invasive procedure which corrects the damaged aortic valve, is often the best option for restoring the heart's normal pumping function.

16 Jun 2016

Interventional Cardiology News and Research

CRF to release new international journal focusing on diagnosis, treatment of structural heart disease

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

NOBLE study shows superiority of CABG over PCI for treatment of left main coronary artery disease

PLATINUM DIVERSITY study evaluates clinical outcomes after stent implantation in women, minorities

RESPECT study: PFO closure more beneficial than medical management in reducing recurrent stroke

TCT 2016 features first report investigations on novel bioresorbable stents

Caisson announces successful human implants of Transcatheter Mitral Valve System

UCLA cardiology expert offers simple tips for heart healthy lifestyle

MedStar Heart & Vascular Institute offers bioresorbable stent for patients with clogged arteries

Direct catheter-based thrombectomy equally effective to bridging thrombolysis in acute ischaemic stroke

Sutter Health among the first to offer Absorb dissolving stent for patients with coronary artery disease

MID's Permaseal transapical access and closure device receives FDA Market clearance

Essential Medical receives CE Mark approval for novel vascular closure device

Loyola among first health systems to offer absorbable stent to heart patients

JACC publishes pivotal data on Tryton’s dedicated coronary bifurcation stent, results submitted to FDA

Radial access gains ground over femoral route for PCI

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Persistent low flow warns of mortality risk after TAVR

Penn researchers explore possibilities to improve outcomes in low flow AS patients treated with TAVR

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News